Responses
Regular and Young Investigator Award Abstracts
Immunotherapy Toxicities
814 Cutaneous immune-related adverse events are protective of mortality in patients treated with anti-PD1 and anti-PDL1 therapy in a multi-institutional cohort study
Compose a Response to This Article
Other responses
No responses have been published for this article.